Simulations Plus, Inc. (NASDAQ:SLP) Q4 2023 Earnings Conference Call October 25, 2023 5:00 PM ET
Company Participants
Tamara Gonzales - Investor Relations, Financial Profiles
Shawn O'Connor - Chief Executive Officer
Will Frederick - Chief Financial Officer
Conference Call Participants
Francois Brisebois - Oppenheimer
Matt Hewitt - Craig-Hallum
David Larsen - BTIG
David Windley - Jefferies
Operator
Greetings, and welcome to the Simulations Plus Fourth Quarter Fiscal 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.
It is now my pleasure to introduce Tamara Gonzales from Financial Profiles. Thank you. Ms. Gonzales, you may now begin.
Tamara Gonzales
Good afternoon, everyone. Welcome to the Simulations Plus fourth quarter and fiscal 2023 financial results conference call.
With me today are Shawn O'Connor, Chief Executive Officer, and Will Frederick, our Chief Financial Officer of Simulations Plus.
Please note that we updated our quarterly earnings presentation, which will serve as a supplement to today's prepared remarks. You can access the presentation on our Investor Relations page at www.simulations-plus.com. After management's commentary, we will open the call for questions.
As a reminder, information discussed today may include forward-looking statements that involve risks and uncertainties. Words like believe, expect and anticipate refer to our best estimates as of this call. There can be no assurances that these will actually take place. So our actual future results could differ significantly from these statements. Further information on the company's risk factors is contained in the Company's quarterly and annual reports and filed with the Securities and Exchange Commission.
With that said, I will turn over the call to Shawn O'Connor. Shawn?
Shawn O'Connor
Thank you, Tamara. Good afternoon, everyone, and thank you for joining us today to discuss our fourth quarter and fiscal 2023 results. We delivered strong revenue and earnings results for fiscal 2023, and I'd especially like to acknowledge our team's impressive execution on building strong customer relationships.
Our team's effort and dedication throughout the year while navigating a challenging environment helped to drive growth and demonstrated the strength of our customer-centric business model. Conditions in our market remain similar to what we have spoken to over the past several quarters. We continue to see a slowdown from small biotech customers who have been impacted by funding scarcity that has in turn affected renewal rates in this segment.